Table 7. Antibiotic resistance of 51 Bcc clinical isolates.
Number of isolates resistant to a given antibiotic is shown for each genomovar (percentage of isolates in brackets).
| Genomovar | N | Tobra | Cipro | Trimet | Mero | Colis | Tet | Ceftaz | Aztreo |
|---|---|---|---|---|---|---|---|---|---|
| B. cenocepacia IIIA | 9 | 9 (100) | 9 (100) | 4 (44) | 1 (11) | 9 (100) | 9(100) | 4 (44) | 4 (44) |
| B. cenocepacia IIIB | 10 | 10 (100) | 10 (100) | 6 (60) | 3 (30) | 10 (100) | 10 (100) | 7 (70) | 8 (80) |
| B.cenocepacia IIID | 1 | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) |
| B. dolasa | 3 | 3 (100) | 3 (100) | 3 (100) | 2 (67) | 3 (100) | 3 (100) | 3 (100) | 3 (100) |
| B. vietnamiensis | 7 | 7 (100) | 7 (100) | 3 (43) | 1 (14) | 7 (100) | 7 (100) | 2 (29) | 3 (43) |
| B. multivorans | 3 | 3 (100) | 3 (100) | 1 (33) | 1 (33) | 3 (100) | 3 (100) | 3 (100) | 3 (100) |
| B. ambifaria | 3 | 3 (100) | 3 (100) | 3 (100) | 0 (0) | 3 (100) | 3 (100) | 1 (33) | 3 (100) |
| B. anthina | 1 | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | 0 (0) |
| B. cepacia | 1 | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 1 (100) |
| B. contaminans | 1 | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | 1 (100) |
| Other Bcc | 12 | 12 (100) | 11 (92) | 7 (58) | 2 (17) | 12 (100) | 11 (92) | 5 (42) | 7 (58) |
| Total resistant | 51 (100) | 50 (98) | 30 (59) | 11 (22) | 51 (100) | 50 (98) | 27 (53) | 34 (67) | |
| Total intermediate | 0 | 1 (2) | 19 (37) | 13 (25) | 0 | 0 | 2 (4) | 0 | |
| Total sensitive | 0 | 0 | 2 (4) | 27 (53) | 0 | 1 (2) | 22 (43) | 17 (33) |
Tobra, tobramycin; Cipro, ciprofloxacin; Trimeth, trimethoprim; Mero, meropenem; Colis, colistin; Tet, tetracycline; Ceftaz, ceftazidime; Aztreo, aztreonam.